Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Affimed Ord Shs
(NQ:
AFMD
)
3.320
+0.050 (+1.53%)
Streaming Delayed Price
Updated: 10:38 AM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Affimed Ord Shs
< Previous
1
2
3
4
5
6
Next >
Lowe's, Alcon And Some Other Big Stocks Moving Higher On Wednesday
November 16, 2022
U.S. stocks traded lower, with the Nasdaq dropping more than 180 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinical and Corporate Progress
November 15, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Engager AFM24 in Solid Tumor Patients at the 37th SITC Annual Meeting
November 07, 2022
From
Affimed N.V.
Via
GlobeNewswire
Recap: Affimed Q2 Earnings
August 11, 2022
Affimed (NASDAQ:AFMD) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Affimed: Q1 Earnings Insights
June 01, 2022
Affimed (NASDAQ:AFMD) reported its Q1 earnings results on Wednesday, June 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For November 15, 2022
November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
Via
Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
November 04, 2022
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.
Via
Benzinga
Recap: Affimed Q4 Earnings
March 31, 2022
Affimed (NASDAQ:AFMD) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
Affimed to Report Third Quarter 2022 Financial Results & Corporate Update on November 15, 2022
November 04, 2022
From
Affimed N.V.
Via
GlobeNewswire
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.
Via
Benzinga
Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101
November 03, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
November 03, 2022
From
Affimed N.V.
Via
GlobeNewswire
Affimed to Present at the 2022 Jefferies London Healthcare Conference
November 01, 2022
From
Affimed N.V.
Via
GlobeNewswire
Why Affimed Stock Plummeted by Over 16% Today
October 10, 2022
An analyst's downgrade brings out the bears for the European cancer treatment developer.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Upgrades
Via
Benzinga
Domino's Pizza To $375? Plus Stifel Cuts Price Target On This Stock By Around 78%
October 10, 2022
Credit Suisse cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $425 to $375. Domino's shares fell 0.3% to $313.70 in pre-market trading.
Via
Benzinga
Affimed Announces Two Clinical Update Presentations on its Novel Bispecific Innate Cell Engager AFM24 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 05, 2022
From
Affimed N.V.
Via
GlobeNewswire
Preview: Affimed's Earnings
August 10, 2022
Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that Affimed will...
Via
Benzinga
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
Despite recession fears, biological sciences will never go out of style, thus benefitting these undervalued biotech stocks to buy.
Via
InvestorPlace
6 Blue-Chip Stocks to Sell Now
July 18, 2022
This article is about 6 blue-chip stocks to sell now. They are severely overvalued or are likely to move down soon with a recession.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
Monday's session saw 84 companies set new 52-week lows.
Via
Benzinga
Earnings Scheduled For June 1, 2022
June 01, 2022
Companies Reporting Before The Bell • Affimed (NASDAQ:AFMD) is projected to report quarterly loss at $0.19 per share on revenue of $10.05 million.
Via
Benzinga
Earnings Preview: Affimed
May 31, 2022
Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Wednesday, 2022-06-01. Here's what investors need to know before the announcement. Analysts estimate that Affimed will...
Via
Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal
Via
Benzinga
Affimed Touts Encouraging Patient Responses For Its NK Cell Therapy In Lymphoma Settings
April 11, 2022
Affimed N.V. (NASDAQ: AFMD)
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 11, 2022
Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
March 31, 2022
Upgrades
Via
Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.